Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5149-5158

  Farilla, Loredana ^a,b   Bulotta, Angela ^a   Hirshberg, Boaz ^c   Li Calzi, Sergio ^a   Khoury, Nasif ^a   Noushmehr, Houtan ^a   Bertolotto, Cristina ^a,b   Di Mario, Umberto ^d   Harlan, David M ^c   Perfetti, Riccardo ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MESSENGER RNA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL NUCLEUS; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN SYNTHESIS; INTRACELLULAR SPACE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

APOPTOSIS; CASPASE 3; CASPASES; CELL SURVIVAL; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; GENE EXPRESSION; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INDOLES; INSULIN; ISLETS OF LANGERHANS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0345374580     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0323     Document Type: Article

References (34)

1. Holst JJ 2002 Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes Metab Res Rev 18:430-441
2. MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB 2002 The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51(Suppl 3):S434-S442
3. Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W 1998 Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetes patients treated with insulin after sulfonylurea secondary failure. Diabetes Care 21:1925-1931
4. Drucker DJ 2003 Glucagon-like peptides regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17:161-171
5. Wang Y, Perfetti R, Greig NH, Holloway HW, De Ore KA, Montrose-Rafizadeh C, Elahi D, Egan JM 1997 Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889
6. Hussain MA, Habener JF 2000 Glucagon-like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic β-cells. Biochem Biophys Res Commun 11:616-619
7. Xu G, Stoffer DA, Habener JF, Bonner-Weir S1999 Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276
8. Farilla L, Hui H, Bertolotto C, Bulotta A, Kang E, Di Mario U, Perfetti R 2002 GLP-1 promotes islet cells growth and inhibits cell apoptosis in Zucker diabetic rats. Endocrinology 143:4397-4408
9. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ 2003 Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis. J Biol Chem 278:471-478
10. Hui H, Nourparvar A, Zhao X, Perfetti R 2003 Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A-and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144:1444-1455
11. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inveradi L, Ricordi C 1997 Improved human islet isolation using a new enzyme blend, liberase. Diabetes 46:1120-1123
12. Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomaselli KJ 1998 In situ detection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 5:1004-1016
13. Weir GC, Bonner-Weir S 1998 Islet transplantation as a treatment for diabetes. J Am Optom Assoc 69:727-732
14. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
15. Gahr S, Merger M, Bollheimer LC, Hammerschmied CG, Scholmerich J, Hugl SR 2002 Hepatocyte growth factor stimulates proliferation of pancreatic β-cells particularly in the presence of subphysiological glucose concentrations. J Mol Endocrinol 28:99-110
16. Yamaoka T, Yoshino K, Yamada T, Yano M, Matsui T, Yamaguchi T, Moritani M, Hata J, Noji S, Itakura M 2002 Transgenic expression of FGF8 and FGF10 induces transdifferentiation of pancreatic islet cells into hepatocytes and exocrine cells. Biochem Biophys Res Commun 292:138-143
17. Edlund H 2001 Factors controlling pancreatic cell differentiation and function. Diabetologia 44:1071-1079
18. Garcia-Ocana A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera JC, Stewart AF 2001 Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50:2752-2762
19. Lopez-Avalos MD, Tatarkiewicz K, Sharma A, Bonner-Weir S, Weir GC 2001 Enhanced maturation of porcine neonatal pancreatic cell clusters with growth factors fails to improve transplantation outcome. Transplantation 71:1154-1162
20. Garcia-Ocana A, Vasavada RC, Takane KK, Cebrian A, Lopez-Talavera JC, Stewart AF 2001 Using β-Cell growth factors to enhance human pancreatic Islet transplantation. J Clin Endocrinol Metab 86:984-988
21. Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, Carlsson C 2001 Regulation of β-cell mass by hormones and growth factors. Diabetes 50(Suppl 1):S25-S29
22. Rhodes CJ 2000 IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication. J Mol Endocrinol 24:303-311
23. Perfetti R, Zhou J, Doyle ME, Egan JM 2000 Glucagon-like peptide 1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141:4600-4605
24. Zhou J, Wang X, Pineyro MA, Egan JM 1999 Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon-and insulin-producing cells. Diabetes 48:2358-2366
25. Tourrel C, Bailbe D, Meile MJ, Kergoat M, Portha B 2001 Glucagon-like peptide-1 and exendin-4 stimulate β-cell neogenesis in streptozotocin- treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50:1562-1570
26. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, Prentki M 2001 Protein kinase C[ζ] activation mediates glucagon-like peptide-1-induced pancreatic ζ-cell proliferation. Diabetes 50:2237-2243
27. De la Tour D, Halvorsen T, Demeterco C, Tyrberg B, Itkin-Ansari P, Loy M, Yoo SJ, Hao E, Bossie S, Levine F 2001 ζ-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 15:476-483
28. Tourrel C, Bailbe D, Lacome M, Meile MJ, Kergoat M, Portha B 2002 Persistent improvement of type 2 diabetes in the Got-Kakazaki rat model by expansion of β-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51:1443-1452
29. Rolin B, Larsen MO, Gotfredsen CF, Deacon CF, Carr RD, Wilken M, Knudsen LB 2002 The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice. Am J Physiol Endocrinol Metab 283:E745-E752
30. Hardikar AA, Wang XY, Williams LJ, Kwok J, Wong R, Yao M, Tuch BE 2002 Functional maturation of fetal porcine β-cells by glucagon-like peptide 1 and cholecystokinin. Endocrinology 143:3505-3514
31. Abraham EJ, Leech CA, Lin JC, Zulewski H, Habener JF 2002 Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 143:3152-3161
32. De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA 2003 Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365-371
33. Suzuki A, Nakauchi H, Taniguchi H 2003 Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA 100:5034-5039
34. Buteau J, Foisy S, Joly E, Prentki M 2003 Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52:124-132